Registry for Long COVID in Children and Adults
Official title: Munich Long COVID Registry for Children, Adolescents, and Adults (MLC-R)
Run by Technical University of Munich · NCT05638724 · Data updated 2026-11-12
This study is collecting information from children and adults who have Long COVID to better understand its effects and help improve care for those affected.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Technical University of Munich Academic / other |
| Locations | 1 site (Munich, Bavaria) |
| Status | Recruiting |
| Started | July 20, 2022 |
| Main results expected | July 20, 2027 |
| Study ends | July 20, 2027 |
| Registry record updated | February 15, 2024 |
| Trial ID | NCT05638724 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals of any age who have experienced confirmed SARS-CoV-2 infection or vaccination and are suffering from post-COVID symptoms.
✕Probably not a fit
Patients whose symptoms can be attributed to other underlying diseases or who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Munich Long COVID Registry aims to gather extensive data on the epidemiology, phenotypes, and disease trajectories of Long COVID across all ages in Germany. This observational study will collect information on individuals who have experienced post-COVID conditions, including symptoms that persist beyond four weeks after acute COVID-19. The registry will serve as a valuable resource for future clinical trials and research into the long-term effects of SARS-CoV-2. By understanding the prevalence and impact of Long COVID, the study seeks to improve healthcare responses and patient outcomes.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of Long COVID, leading to better treatment options and improved quality of life for affected patients.
How similar studies have gone: Other studies have shown promise in understanding Long COVID, but this registry approach is relatively novel in its comprehensive data collection across different age groups.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: I. Written informed consent of the patient or legal guardian. II. Confirmed SARS-CoV-2 vaccination and/or confirmed or probable SARS-CoV-2 infection: Positive SARS-CoV-2 polymerase chain reaction (PCR) or rapid antigen test (AST), documented probable COVID-19 (e.g., typical CT scan), probable COVID-19 with a history of high-risk contact, anti-SARS-CoV-2-N antibodies (and/or in non-vaccinated people -S-IgG antibodies) following probable COVID-19. III. Additional ICD-10 codes: U09.9!V: Suspected post-COVID-19 condition, unspecified; U12.9!V: suspected adverse reactions to COVID-19 vaccine use, unspecified (post-COVIDvac condition). Exclusion Criteria: * Any subsequent medical data that question the diagnosis of PCC or post-COVIDvac condition * Clinical picture can be explained by another underlying disease. * Pregnancy
Where it's running
-
MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital
Munich, Bavaria, Germany Recruiting
Study contacts
- Principal investigator: Uta Behrends, Prof. Dr. med. — MRI Chronic Fatigue Center for Young People (MCFC), Children's Hospital, Technical University of Munich & Munich Municipal Hospital
- Study coordinator: Uta Behrends, Prof. Dr. med.
- Email: uta.behrends@tum.de
- Phone: +4989 3068 2632
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Micro-choice-based approach to fatigue management
A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.
-
SuperCAP program to help cognition and daily functioning after COVID-19
A digital program called SuperCAP is being tested to see if it can reduce disability in adults with long COVID compared to standard care.
-
Sonlicromanol for post-COVID fatigue with post-exertional malaise.
This trial will test whether taking sonlicromanol can reduce fatigue and post-exertional malaise in adults who meet WHO criteria for post-COVID and had a mild initial infection.
-
Cold water hydrotherapy to support rehabilitation in Post-COVID Syndrome
This tests whether adding cold water hydrotherapy to standard rehabilitation helps people with Post-COVID Syndrome improve their quality of life.
-
Rehabilitation program to reduce fatigue after COVID-19
This study is testing a new rehabilitation program called COVIDEx to see if it can help people with Long COVID feel less tired compared to standard care.
-
Mitochondrial oxygen use in blood, muscle, and skin of people with long COVID
Researchers will test whether mitochondria use oxygen differently in blood cells, muscle, and skin of people with long COVID compared with people who fully recovered after COVID-19.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.